alexa Development Of Five Hyper-humanized Antibodies Neutralizing The Botulinum Neurotoxins A, B And E: The European AntiBotABE Project | 72479
ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

6th Euro-Global Conference on Infectious Diseases

Arnaud Avril, Sebastian Miethe, Michel R Popoff, Christelle Mazuet, Christine Rasetti-escargueil, Hannu Korkeala, Dorothea Sesardic, Thibaut Pelat, and Michael Hust
Institut de Recherche Biomédicale des Armées, France
Technische Universität Braunschweig, Germany
Unit of Anaerobic Bacteria and Toxins and National Reference Center of Anaerobic Bacteria and Botulism, Paris, France
National Institute for Biological Standards and Control, United Kingdom
University of Helsinki, Finland
Biotem, France
ScientificTracks Abstracts: J Infect Dis Ther
DOI: 10.4172/2332-0877-C1-032
Abstract
Botulism is a naturally occurring disease, mainly caused by the ingestion of food contaminated by one of the 7 serotypes (A to G) of botulinum neurotoxins (BoNTs). BoNT/A is the most lethal biological substance currently known, with a human 50% lethal dose estimated at 1 ng.kg-1, and they are classified among the 6 major biological warfare agents. AntiBotABE, a European Framework, 7 funded projects aimed to develop 6 humanized IgGs, neutralizing BoNT serotypes A, B and E by targeting their heavy (HC) and light chains (LC). Six macaques were immunized with the recombinant LC or HC of BoNT/A, B or E, and their corresponding immune libraries were generated and screened by phage-display. After each panning, the most reactive scFv were isolated and their affinity measured. Inhibition or neutralization capacities were determined in vitro (SNAP25 or VAMP2 endopeptidasic assay) or ex vivo (mouse phrenic nerve-diaphragm assay). Neutralizing scFvs were identified for 5 of the 6 antigens. For each of the 5 libraries, the most efficient scFv was germline-humanized and expressed as full-length IgG. In the mouse bioassays, 3/5 IgGs alone and all IgGs in pairs, protected mice from paralysis or death after a challenge with the respective BoNT serotype. 1–5 Antibodies isolated during this project are potential lead candidates for further clinical development and we are looking for clinical development opportunity.
Biography

Arnaud Avril works for the French Armed Forces Biomedical Research Institute (IRBA), based in Paris area. He has a Master degree in Genetic and Immunology from Lyon University (France) and a PhD in Biotechnology applied to antibodies from the Grenoble-Alpes University (France). He is the Head of a team specialized in the research, development and engineering of recombinant antibodies against rare diseases for biodefense. He has developed germline-humanized recombinant antibodies starting from non-human primates immunized with non-toxic antigens. He has contributed to the development of several antibodies neutralizing botulinum neurotoxins, anthrax, ricin and Orthopoxvirus. He has also contributed to the development immuno-diagnostic assays for the rapid, convenient and cheap detection of biological agents, for armed forces, medical staff and first responders. He is involved as an expert on the clinical development of a recombinant antibody for anthrax therapy.

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

medicalj[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7